• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec31
Distribution Plan(EST)

Cash dividend 0.1346 USD

Dec24
Distribution Plan(EST)

Cash dividend 0.1346 USD

Distribution Plan(EST)

Cash dividend 0.1346 USD

View More

Event Tracking

Dec25
AstraZeneca's Vilumatin Approved in China for ATTRv-PN Treatment
09:22
AstraZeneca's Enhertu Approved for New Indication
08:41
DS-8201 Receives New Indication Approval in China for Previously Treated HR+, HER2-Low Advanced Breast Cancer
05:45
AstraZeneca and JABYO Enter into a License Agreement, Jacada Shares Under Pressure
01:04
Dec24
Gilead Sciences to Acquire Repare Therapeutics' Cancer Treatment Drugs
12:38
Global X Japan Co. Ltd. Significantly Increases Holdings in Gilead Sciences
09:44